Macular edema is the condition when the fluid and proteins start
collecting on or under the macula of the eye thereby resulting in swelling.
Due to such swelling, a person’s central eye vision gets distorted.
Macular edema is classified into two types namely cystoids macular edema (CME)
and diabetic macular edema (DME).
Diabetic macular edema is the major reason for loss of vision in
patients suffering from diabetic retinopathy. Diabetes patient are reported to
have a 10% risk of developing this condition during their lifetime. On the
basis of the cause of disease, DME is classified into two types:
- Diffuse macular
edema: due to abnormalities in dilated capillaries present in the retina.
- Focal macular edema:
due to abnormalities in microaneurysms
Browse
Full Report with TOC: http://www.transparencymarketresearch.com/diabetic-macular-edema-market.html
For diagnosing diabetic macular edema, an ophthalmologist checks the
retina for symptoms of the disease including leaking blood vessel, retinal
swelling, damaged nerve tissues and pale, fatty deposits on the retina. For
further confirmation, comprehensive eye examination such as visual acuity test,
dilated exam test and tonometry are performed.
During the initial stages of DME, no treatment is needed unless the
patients efficiently control their blood sugar levels. If the condition becomes
severe, the standard treatment for diabetic macular edema is laser
photocoagulation. This procedure utilizes laser to reduce edema byapplying a
pattern of burnsor bycauterizing leaky blood vessels. For avoiding the
side-effects of this treatment, retinal specialists apply injections of
anti-vascular endothelial growth factorcorticosteroids along with laser
photocoagulation. Currently, there are only two approved drugs available in
market for treating DME namely Lucentis and Ozurdex. Other treatment methods
are currently under clinical trials.
The markets for America and Europe are at the maturity stage for diabetic
macular edema because large proportion of population is suffering from
diabetes. Lucentis and Ozurdex ocuppy the major part of the market share in the
therapeutics market. Asia-Pacific is also growing at faster pace while the
markets of Africa and Australia are currently at initial stages. Some of the
companies and institutes which are involved in clinical trials for treatment of
diabetic macular edema are Allergan, Inc., Novartis AG, F. Hoffmann-La Roche
Ltd., Regeneron Pharmaceuticals, Inc., Pfizer, Inc.,Bayer AG, Bausch & Lomb
Incorporated,the Diabetic Retinopathy Clinical Research Network, The National
Eye Institute, Johns Hopkins University and ShahidBeheshti University of
Medical Sciences.
Download PDF: Diabetic Macular Edema Market
This
research report analyzes this market depending on its market segments, major
geographies, and current market trends. Geographies analyzed under this
research report include
- North America
- Asia Pacific
- Europe
- Rest of the World
This
report provides comprehensive analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming
years
This
report is a complete study of current trends in the market, industry growth
drivers, and restraints. It provides market projections for the coming years.
It includes analysis of recent developments in technology, Porter’s five force
model analysis and detailed profiles of top industry players. The report also
includes a review of micro and macro factors essential for the existing market
players and new entrants along with detailed value chain analysis.
Reasons
for Buying this Report
- This report provides pin-point
analysis for changing competitive dynamics
- It provides a forward looking
perspective on different factors driving or restraining market
growth
- It provides a technological growth
map over time to understand the industry growth rate
- It provides a seven-year forecast
assessed on the basis of how the market is predicted to grow
·
It helps in making informed business
decisions by having complete insights of market and by making in-depth analysis
of market segments
More Reports On Pharmaceutical
Market: http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html
About Us:-
Transparency Market
Research (TMR) is a market intelligence company providing global business
research reports and consulting services. Our exclusive blend of quantitative
forecasting and trends analysis provides forward-looking insights for thousands
of decision-makers.
TMR’s
experienced team of analysts, researchers, and consultants use proprietary data
sources along with various tools and techniques to gather and analyze
information. Our business offerings represent the latest and the most reliable
information which is indispensable for businesses to sustain their competitive
edge.
Our
data repository is continuously updated and revised by a team of research
experts so that it always reflects the latest trends and information. With
broad research and analysis capability, Transparency Market Research employs
rigorous primary and secondary research techniques in developing distinctive
data sets and research material for business reports.
Contact
Us
Sheela
AK
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
Tel: +1-518-618-1030
Browse
Market Researche Report:-
0 comments:
Post a Comment